Motley Fool Money cover image

No Artificial Sweetener for Uber

Motley Fool Money

00:00

ServiceNow and Vertex: Innovating for Impact

This chapter examines ServiceNow's growth and competitive strategies in the enterprise software space, particularly its advancements in productivity and profitability. It also highlights Vertex Pharmaceuticals' stability and innovation in therapies for critical diseases, focusing on its groundbreaking drug Trikafta and ambitious future projects.

Play episode from 25:54
Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app